Ovarian response to stimulation of HIV-positive patients during IVF treatment: A matched, controlled study

Human Reproduction

Volumn 21, Issue 5, 2006, Pages 1212-1217

  Martinet, Valérie ^a   Manigart, Yannick ^a   Rozenberg, Serge ^a   Becker, Benedicte ^a   Gerard, Michèle ^b   Delvigne, Annick ^a  

^a SAINT PIERRE UNIVERSITY HOSPITAL   (Belgium)

^b UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

Author keywords

Case control study; HIV; IVF; Poor response

Indexed keywords

ESTRADIOL; GONADOTROPIN;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE DURATION; EMBRYO TRANSFER; FEMALE; FEMALE INFERTILITY; FERTILIZATION IN VITRO; HEALTH STATUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRACYTOPLASMIC SPERM INJECTION; MAJOR CLINICAL STUDY; MATERNAL AGE; NEGRO; OVARY FOLLICLE MATURATION; OVARY FUNCTION; OVULATION INDUCTION; PELVIC INFLAMMATORY DISEASE; PELVIS SURGERY; TREATMENT OUTCOME; UNIVERSITY HOSPITAL;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 33645836727     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/dei493     Document Type: Article

References (44)

1. Augood C, Duckitt K and Templeton AA (1998) Smoking and female infertility: A systematic review and meta-analysis. Hum Reprod 13,1532-1539.
2. Bancsi LF, Broekmans FJ, Eijkemans MJ, de Jong FH, Habbema JD and te Velde ER (2002) Predictors of poor ovarian response in in vitro fertilization: A prospective study comparing basal markers of ovarian reserve. Fertil Steril 77,328-336.
3. Bancsi LF, Broekmans FJ, Mol BW, Habbema JD and te Velde ER (2003) Performance of basal follicle-stimulating hormone in the prediction of poor ovarian response and failure to become pregnant after in vitro fertilization: A meta-analysis. Fertil Steril 79,1091-1100.
4. Brettle RP, Raab GM, Ross A, Fielding KL, Gore SM and Bird AG (1995) HIV infection in women: Immunological markers and the influence of pregnancy. AIDS 9,1177-1184.
5. Bujan L, Pasquier C, Labeyrie E, Lanusse-Crousse P, Morucci M and Daudin M (2004) Insemination with isolated and virologically tested spermatozoa is a safe way for human immunodeficiency type 1 virus-serodiscordant couples with an infected male partner to have a child. Fertil Steril 82,857-862.
6. Bukman A and Heineman MJ (2001) Ovarian reserve testing and the use of prognostic models in patients with subfertility. Hum Reprod Update 7,581-590.
7. Chirgwin KD, Feldman J, Muneyyirci-Delale O, Landesman S and Minkoff H (1996) Menstrual function in human immunodeficiency virus-infected women without acquired immunodeficiency syndrome. J Acquir Immune Defic Syndr Hum Retrovirol 12,489-494.
8. Cicero TJ, Meyer ER, Bell RD and Wiest WG (1974) Effect of morphine on secondary sex organs and plasma testosterone levels in rats. Res Commun Chem Pathol Pharmacol 7,17-24.
9. Clark RA, Cohn SE, Jarek C, Craven KS, Lyons C, Jacobson M and Kamemoto L (2000) Perimenopausal symptomatology among HIV-infected women at least 40 years of age. J Acquir Immune Defic Syndr 23,99-100.
10. Clark RA, Mulligan K, Stamenovic E, Chang B, Watts H, Andersen J, Squires K and Benson C (2001) Frequency of anovulation and early menopause among women enrolled in selected adult AIDS clinical trials Group studies. J Infect Dis 184,1325-1327.
11. Coll O, Fiore S, Floridia M, Giaquinto C, Grosch-Worner I, Guiliano M, Lindgren S, Lyall H, Mandelbrot L, Newell ML, Peckham C, Rudin C, Semprini AE, Thorne C and Tovo PA (2002) Pregnancy and HIV infection: A european consensus on management. AIDS 16 (Suppl. 2),S1-S18.
12. Coll O, Vernaeve V, Mataro, D, Durban M, Figueras F, Martinez E, Vidal R (2005) Associated factors to the low reproductive outcome in infertile HIV infected women. Human Reprod 20 (51): Abstract 0-022.
13. Cooper OB, Brown TT and Dobs AS (2003) Opiate drug use: A potential contributor to the endocrine and metabolic complications in human immunodeficiency virus disease. Clin Infect Dis 37 (Suppl. 2),S132-S136.
14. Csemiczky G, Landgren BM, Fried G and Wramsby H (1996) High tubal damage grade is associated with low pregnancy rate in women undergoing in-vitro fertilization treatment. Hum Reprod 11,2438-2440.
15. Cu-Uvin S, Wright DJ, Anderson D, Kovacs A, Watts DH, Cohn J, Landay A and Reichelderfer PS (2000) Hormonal levels among HIV-1-seropositive women compared with high-risk HIV-seronegative women during the menstrual cycle. Women's Health Study (WHS) 001 and WHS 001a Study Team. J Womens Health Gend Based Med 9,857-863.
16. De Boer EJ, den Tonkelaar I, te Velde ER, Burger CW, Klip H, van Leeuwen FE and OMEGA-project Group (2002) A low number of retrieved oocytes at in vitro fertilization treatment is predictive of early menopause. Fertil Steril 77,978-985.
17. Delvigne A, Gerard M and Rozenberg S (2001) Fertility treatment in HIV needs multidisciplinary team. BMJ 323,53.
18. Delvigne A, Kostyla K, Murillo D, Van Hoek J and Rozenberg S (2003) Oocyte quality and IVF outcome after coasting to prevent ovarian hyper-stimulation syndrome. Int J Fertil 48,25-31.
19. Dokras A, Sargent IL and Barlow DH (1993) Human blastocyst grading: An indicator of developmental potential? Hum Reprod 8,2119-2127.
20. Ellerbrock TV, Wright TC, Bush TJ, Dole P, Brudney K and Chiasson MA (1996) Characteristics of menstruation in women infected with human immunodeficiency virus. Obstet Gynecol 87,1030-1034.
21. El-Nemr A, Al-Shawaf T, Sabatini L, Wilson C, Lower AM and Grudzinskas JG (1998) Effect of smoking on ovarian reserve and ovarian stimulation in in-vitro fertilization and embryo transfer. Hum Reprod 13,2192-2198.
22. Englert Y, Van Vooren JP, Place I, Liesnard C, Laruelle C and Delbaere A (2001) ART in HIV-infected couples: Has the time come for a change of attitude? Hum Reprod 16,1309-1315.
23. Fedorcsak P, Dale PO, Storeng R, Ertzeid G, Bjercke S, Oldereid N, Omland AK, Abyholm T and Tanbo T (2004) Impact of overweight and underweight on assisted reproduction treatment. Hum Reprod 19,2523-2528.
24. Garrido N, Meseguer M, Bellver J, Remohi J, Simon C and Pellicer A (2004) Report of the results of a 2 year programme of sperm wash and ICSI treatment for human immunodeficiency virus and hepatitis C virus serodiscordant couples. Hum Reprod 19,2581-2586.
25. Gray RH, Wawer MJ, Serwadda D, Sewankambo N, Li C, Wabwire-Mangen F, Paxton L, Kiwanuka N, Kigozi G, Konde-Lule J, Quinn TC, Gaydos CA and McNairn D (1998) Population-based study of fertility in women with HIV-1 infection in Uganda. Lancet 351,98-103.
26. Grinspoon S, Corcoran C, Miller K, Biller BM, Askari H, Wang E, Hubbard J, Anderson EJ, Basgoz N, Heller HM and Klibanski A (1997) Body composition and endocrine function in women with acquired immunodeficiency syndrome wasting. J Clin Endocrinol Metab 82,1332-1337.
27. Guibert J et al. (2004) Femme séropositive: Problème de VIH ou/et de fertilité. In Troisièmes Journées Nationales "Désir d'enfant et VIH", 7/05/2004, Toulouse.
28. Harlow SD, Schuman P, Cohen M, Ohmit SE, Cu-Uvin S, Lin X, Anastos K, Burns D, Greenblatt R, Minkoff H, Muderspach L, Warren D, Young MA and Klein RS (2000) Effect of HIV infection on menstrual cycle length. J Acquir Immune Defic Syndr 24,68-75.
29. Kailasam C, Keay SD, Wilson P, Ford WC and Jenkins JM (2004) Defining poor ovarian response during IVF cycles, in women aged <40 years, and its relationship with treatment outcome. Hum Reprod 19,1544-1547 (Epub).
30. Keay SD, Liversedge NH and Jenkins JM (1998) Could ovarian infection impair ovarian response to gonadotrophin stimulation? Br J Obstet Gynaecol 105,252-253.
31. Klinkert ER, Broekmans FJ, Looman CW, Habbema JD and te Velde ER (2005) The antral follicle count is a better marker than basal follicle-stimulating hormone for the selection of older patients with acceptable pregnancy prospects after in vitro fertilization. Fertil Steril 83,811-814.
32. Lo JC and Schambelan M (2001) Reproductive function in human immunodeficiency virus infection. J Clin Endocrinol Metab 86,2338-2343.
33. Minkoff H and Santoro N (2000) Ethical considerations in the treatment of infertility in women with human immunodeficiency virus infection. N Engl J Med 342,1748-1750.
34. Nikolaou D and Templeton A (2004) Early ovarian ageing. Eur J Obstet Gynecol Reprod Biol 113,126-133.
35. Ohl J, Partisani M, Wittemer C, Lang JM, Viville S and Favre R (2005) Encouraging results despite complexity of multidisciplinary care of HIV-infected women using assisted reproduction techniques. Hum Reprod 20,3136-3140 (Epub ahead of print).
36. Ohl J, Partisani M, Wittemer C, Schmitt MP, Cranz C, Stoll-Keller F, Rongieres C, Bettahar-Lebugle K, Lang JM and Nisand I (2003) Assisted reproduction techniques for HIV serodiscordant couples: 18 months of experience. Hum Reprod 18,1244-1249.
37. Saada M, Le Chenadec J, Berrebi A, Bongain A, Delfraissy JF, Mayaux MJ and Meyer L (2000) Pregnancy and progression to AIDS: Results of the French prospective cohorts. SEROGEST and SEROCO Study Groups AIDS 14,2355-2360.
38. Semprini AE and Fiore S (2004) HIV and reproduction. Curr Opin Obstet Gynecol 16,257-262.
39. Shah PN, Smith JR, Wells C, Barton SE, Kitchen VS and Steer PJ (1994) Menstrual symptoms in women infected by the human immunodeficiency virus. Obstet Gynecol 83,397-400.
40. Smith CG and Asch RH (1987) Drug abuse and reproduction. Fertil Steril 48,355-373.
41. Surrey ES and Schoolcraft WB (2000) Evaluating strategies for improving ovarian response of the poor responder undergoing assisted reproductive techniques. Fertil Steril 73,667-676.
42. Tarlatzis B, Zepiridis L, Grimbizis G and Bontis J (2003) Clinical management of low ovarian response to stimulation for IVF: A systematic review. Hum Reprod Update 9,61-76.
43. Terriou P, Auquier P, Chabert-Orsini V, Chinchole JM, Cravello L, Giorgetti C, Halfon P, Salzmann J and Roulier R (2005) Outcome of ICSI in HIV-1-infected women. Hum Reprod 20,2838-2843 (Epub ahead of print).
44. Yaro S, Meda N, Desgrees Du Lou A, Sombie I, Cartoux M, Tiendrebeogo S, Ouangre A, Dao B, Nacro B, Kpozehouen A, Nebie Y, Van De Perre P, Mandelbrot L and Dabis F (2001) [Impaired fertility in women infected with HIV-1. Implications for sentinel serosurveillance]. Rev Epidemiol Sante Publique 49,221-228.